Abstract
IntroductionDespite advancements in managing atherosclerotic cardiovascular disease (ASCVD), mortality and morbidity rates remain high. This is partially attributed to systemic inflammation (SI) which leads to increased cardiovascular risk in people...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
